Etravirine
Who holds supplier records for Etravirine? 4 organisations hold a current record for Etravirine: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3) and Belgium (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Etravirine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/etravirine
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
3 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Etravirine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 35835, 25550 · latest filing Jun 2021
- MSN LIFE SCIENCES PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 29404 · latest filing May 2015
- Janssen Pharmaceutica NVBelgium Company GMP cert on recordActive DMF 20440 · latest filing Apr 2007
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 28813 · latest filing Dec 2014
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (1)
Certificates of Suitability on the EDQM register for Etravirine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MSN LIFE SCIENCES PRIVATE LIMITED Medak | IN | CEP 2025-023 - Rev 00 Etravirine, Form-I | May 2026 | Inspected Oct 2025 Slovakia |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Etravirine are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Apotex Pharmachem India Pvt. Ltd.India · Inactive DMF 27923 · filed Mar 2014
- France · Inactive DMF 15683 · filed Oct 2001
Overview
Etravirine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL308954).
Chemical identity
- IUPAC name
- 4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile
- Canonical SMILES
- CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N
- InChIKey
- PYGWGZALEOIKDF-UHFFFAOYSA-N
- Synonyms
- Etravirina, Etravirine, Intelence, R-165335, R165335, TMC 125, TMC-125, TMC125, TMC125 cpd, CHEBI:63589, etravirinum, RefChem:57536
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- Mechanism of action
- Cytochrome P450 2C19 Inhibitors; Cytochrome P450 2C9 Inhibitors; Cytochrome P450 3A Inducers; Non-Nucleoside Reverse Transcriptase Inhibitors; P-Glycoprotein Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Etravirine?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Etravirine: Hetero Labs Limited (India), MSN LIFE SCIENCES PRIVATE LIMITED (India), Janssen Pharmaceutica NV (Belgium) and MATRIX PHARMACORP PRIVATE LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Etravirine Drug Master Files are active?
Hetero Labs Limited (DMF 35835, 25550), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 29404), Janssen Pharmaceutica NV (DMF 20440) and MATRIX PHARMACORP PRIVATE LTD (DMF 28813). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Etravirine records mean?
2 organisations have only inactive Type II DMFs for Etravirine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Etravirine have a European Certificate of Suitability?
Yes. 1 organisation holds a valid CEP for Etravirine on the EDQM register, including MSN LIFE SCIENCES PRIVATE LIMITED Medak (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Etravirine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Etravirine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.